Product Information
BONSITY 560 MCG/2.24 ML PEN is a generic product labeled by Alvogen Inc., priced at $536.5490 per ML under NDC 47781085289. Its NADAC has been published 47 times since Aug 6, 2025.
Strength
250 ug/mL
Manufacturer
Alvogen Inc.NDC
47781085289
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Last Updated
6/17/2026
Active Ingredients
TERIPARATIDEApproval Type
New Drug (NDA)
FDA Application
NDA211939On Market Since
6/6/2025
Pharmacological Classes
Price Statistics
The NADAC for BONSITY 560 MCG/2.24 ML PEN has been published 47 times since Aug 6, 2025, and over the history we have for it it has declined 36.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $536.5490 per ML |
|---|---|
| All-time high | $846.0749 (Oct 15, 2025) |
| All-time low | $535.0936 (May 20, 2026) |
| 52-week high | $846.0749 |
| 52-week low | $535.0936 |
| Median price | $673.2483 |
| Average price | $673.4934 |
| Largest weekly change | -20.7% (Oct 22, 2025) |
| Weeks tracked | 47 |
| Tracking since | Aug 6, 2025 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BONSITY 560 MCG/2.24 ML PEN?
The current National Average Drug Acquisition Cost (NADAC) for BONSITY 560 MCG/2.24 ML PEN, manufactured by Alvogen Inc., is $536.5490 per ML (NDC 47781085289), effective Jun 24, 2026.
How has the price of BONSITY 560 MCG/2.24 ML PEN changed over time?
Over the history we have for it, the NADAC for BONSITY 560 MCG/2.24 ML PEN has declined 36.6%. It has been tracked across 47 weekly CMS publications since Aug 6, 2025.
What are the highest and lowest recorded NADAC prices for BONSITY 560 MCG/2.24 ML PEN?
Since Aug 6, 2025, the NADAC for BONSITY 560 MCG/2.24 ML PEN has ranged from a low of $535.0936 (May 20, 2026) to a high of $846.0749 (Oct 15, 2025), with a median of $673.2483 per ML.
Are there cheaper alternatives to BONSITY 560 MCG/2.24 ML PEN?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as BONSITY 560 MCG/2.24 ML PEN, but none are currently priced below it.
Who manufactures BONSITY 560 MCG/2.24 ML PEN?
BONSITY 560 MCG/2.24 ML PEN (NDC 47781085289) is labeled by Alvogen Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification